Many of the regulators identified in our study had previously been identified to be associated with TGF-β signaling, EMT, or lung cancer [43,44,45,46,47,48,49,50,51,52,53,54,56,57,58,59,61,62,63,64,65,66,67,68,69]. This evidence concerns the gene TGFB1 and lung carcinoma.